When you eat less food, your body converts fat and muscle into energy
If you're considering stopping GLP-1 therapy or exploring alternatives , several evidence-based approaches can help maintain metabolic improvements and manage weight or blood glucose levels effectively
This work bridges technical innovation with local needs, offering a holistic perspective on urban decarbonization.Speakers: Ms Elsen Aydin (ODT-GNAM), Ms lkim Canl (ODT-GNAM), Prof
Jaikumkao, K., Pongchaidecha, A., Chattipakorn, N., Chatsudthipong, V., Promsan, S., Arjinajarn, P., & Lungkaphin, A
GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available